AMFPF
Price
$23.85
Change
+$1.83 (+8.31%)
Updated
Jun 4 closing price
Capitalization
8.23B
MAHLY
Price
$16.01
Change
+$0.96 (+6.38%)
Updated
Jun 27 closing price
Capitalization
3.69B
Interact to see
Advertisement

AMFPF vs MAHLY

Header iconAMFPF vs MAHLY Comparison
Open Charts AMFPF vs MAHLYBanner chart's image
Amplifon S.p.A
Price$23.85
Change+$1.83 (+8.31%)
Volume$500
Capitalization8.23B
Medipal Holdings
Price$16.01
Change+$0.96 (+6.38%)
Volume$3.04K
Capitalization3.69B
AMFPF vs MAHLY Comparison Chart in %
Loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. MAHLY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and MAHLY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMFPF: $23.85 vs. MAHLY: $16.01)
Brand notoriety: AMFPF and MAHLY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 31% vs. MAHLY: 139%
Market capitalization -- AMFPF: $8.23B vs. MAHLY: $3.69B
AMFPF [@Medical Distributors] is valued at $8.23B. MAHLY’s [@Medical Distributors] market capitalization is $3.69B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileMAHLY’s FA Score has 0 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • MAHLY’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMFPF and MAHLY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 2 TA indicator(s) are bullish while MAHLY’s TA Score has 2 bullish TA indicator(s).

  • AMFPF’s TA Score: 2 bullish, 1 bearish.
  • MAHLY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AMFPF is a better buy in the short-term than MAHLY.

Price Growth

AMFPF (@Medical Distributors) experienced а 0.00% price change this week, while MAHLY (@Medical Distributors) price change was +6.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($8.23B) has a higher market cap than MAHLY($3.69B). AMFPF has higher P/E ratio than MAHLY: AMFPF (40.21) vs MAHLY (13.48). MAHLY YTD gains are higher at: -0.404 vs. AMFPF (-8.278). MAHLY has higher annual earnings (EBITDA): 74B vs. AMFPF (520M). MAHLY has more cash in the bank: 252B vs. AMFPF (198M). AMFPF has less debt than MAHLY: AMFPF (1.58B) vs MAHLY (30B). MAHLY has higher revenues than AMFPF: MAHLY (3.35T) vs AMFPF (2.22B).
AMFPFMAHLYAMFPF / MAHLY
Capitalization8.23B3.69B223%
EBITDA520M74B1%
Gain YTD-8.278-0.4042,047%
P/E Ratio40.2113.48298%
Revenue2.22B3.35T0%
Total Cash198M252B0%
Total Debt1.58B30B5%
FUNDAMENTALS RATINGS
AMFPF vs MAHLY: Fundamental Ratings
AMFPF
MAHLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
6041
PRICE GROWTH RATING
1..100
5954
P/E GROWTH RATING
1..100
8762
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMFPF's Valuation (37) in the null industry is somewhat better than the same rating for MAHLY (86). This means that AMFPF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

AMFPF's Profit vs Risk Rating (96) in the null industry is in the same range as MAHLY (100). This means that AMFPF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's SMR Rating (41) in the null industry is in the same range as AMFPF (60). This means that MAHLY’s stock grew similarly to AMFPF’s over the last 12 months.

MAHLY's Price Growth Rating (54) in the null industry is in the same range as AMFPF (59). This means that MAHLY’s stock grew similarly to AMFPF’s over the last 12 months.

MAHLY's P/E Growth Rating (62) in the null industry is in the same range as AMFPF (87). This means that MAHLY’s stock grew similarly to AMFPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFMAHLY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
10%
Bearish Trend 4 days ago
43%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
43%
MACD
ODDS (%)
Bearish Trend 4 days ago
28%
Bullish Trend 4 days ago
24%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
28%
Bullish Trend 4 days ago
34%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
28%
Bullish Trend 4 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
40%
Aroon
ODDS (%)
Bullish Trend 4 days ago
13%
Bearish Trend 4 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYI10.630.02
+0.19%
Blackrock Muniyield Quality Fund III
JMHI49.650.06
+0.12%
JPMorgan High Yield Municipal ETF
USSH50.58-0.06
-0.11%
WisdomTree 1-3 Year Laddered Trsy ETF
GBTC86.07-0.36
-0.42%
Grayscale Bitcoin Trust ETF
NVDQ1.34-0.04
-2.55%
T-REX 2X Inverse NVIDIA Daily Target ETF

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and COR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and COR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
COR - AMFPF
24%
Poorly correlated
+1.74%
ZYXI - AMFPF
7%
Poorly correlated
-10.78%
NSVGF - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
ARRJF - AMFPF
-0%
Poorly correlated
N/A
More

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
-10.78%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More